- You are viewing a Navigating Care library resource.
- Go to Library
Treatment of Acute Myeloid Leukemia in Remission
For information about the treatments listed below, see the Treatment Option Overview section.
Treatment of acute myeloid leukemia (AML) during the remission phase depends on the subtype of AML and may include the following:
- Combination chemotherapy.
- Maintenance therapy with midostaurin, for patients whose AML has a mutated (changed) form of the FLT3 gene.
- Maintenance therapy with chemotherapy.
- High-dose chemotherapy and stem cell transplant using the patient's stem cells.
- High-dose chemotherapy, with or without radiation therapy, or reduced-intensity therapy, followed by a stem cell transplant using donor stem cells.
Use our clinical trial search to find NCI-supported cancer clinical trials that are accepting patients. You can search for trials based on the type of cancer, the age of the patient, and where the trials are being done. General information about clinical trials is also available.
Learn more:
- General Information About Acute Myeloid Leukemia
- Stages of Acute Myeloid Leukemia
- Treatment Option Overview
- Treatment of Untreated Acute Myeloid Leukemia
- Treatment of Acute Myeloid Leukemia in Remission
- Treatment of Refractory or Recurrent Acute Myeloid Leukemia
- Treatment of Acute Promyelocytic Leukemia (APL)
- Treatment of Recurrent Acute Promyelocytic Leukemia (APL)
- To Learn More About Adult Acute Myeloid Leukemia Cancer
Related Articles
- General Information About Acute Myeloid Leukemia
- Stages of Acute Myeloid Leukemia
- Treatment Option Overview
- Treatment of Untreated Acute Myeloid Leukemia
- Treatment of Acute Myeloid Leukemia in Remission
- Treatment of Refractory or Recurrent Acute Myeloid Leukemia
- Treatment of Acute Promyelocytic Leukemia (APL)
- Treatment of Recurrent Acute Promyelocytic Leukemia (APL)
- To Learn More About Adult Acute Myeloid Leukemia Cancer